4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-26-112062
Chief Executive Officer sold 31,550 shares at $36.57 ($1,153,784)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2026-09-25 | Sale 10b5-1 | −31,550 | $36.57 | $1,153,784 | 2,213,090 | D |
| Open-market sales · 31,550 sh · avg $36.57 · $1,153,784 | |||||||
Loading xslF345X06/tm2626627-4_4seq1.xml…